How were Nuwellis' earnings last quarter?

Nuwellis, Inc. (NASDAQ:CHFS) issued its earnings results on Monday, March, 1st. The company reported ($1.57) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.91) by $0.34. The company had revenue of $2.04 million for the quarter. Nuwellis had a negative net margin of 254.26% and a negative trailing twelve-month return on equity of 173.61%.

When did Nuwellis' stock split?

Nuwellis shares reverse split before market open on Friday, October 13th 2017. The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 12th 2017. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Nuwellis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nuwellis investors own include Biocept (BIOC) , Immutep (IMMP) , Tonix Pharmaceuticals (TNXP) , T2 Biosystems (TTOO) , Zosano Pharma (ZSAN) , Avinger (AVGR) , Co-Diagnostics (CODX) , iBio (IBIO) , Inovio Pharmaceuticals (INO) and Onconova Therapeutics (ONTX) .

NASDAQ:CHFS

Nuwellis (CHFS) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free CHFS Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $0.24
▼
$0.28
50-Day Range: $3.53
▼
$6.02
52-Week Range: $4.86
▼
$37.50

Volume: 236,196 shs
Average Volume: 467,323 shs
Market Capitalization: $1.55 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Competitors Social Media

Get Nuwellis alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Nuwellis Stock (NASDAQ:CHFS)

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

Find out more here >>>

CHFS Stock News Headlines

April 10, 2024 | finance.yahoo.com

Nuwellis, Inc. (NUWE) Interactive Stock Chart - Yahoo Finance

September 11, 2023 | investorplace.com

Why Is Nuwellis (NUWE) Stock Down Today?

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

May 4, 2023 | forbes.com

BetterHelp Online Therapy Review 2023

March 11, 2023 | forbes.com

Best Prenatal Vitamins Of 2023, According To Experts

February 20, 2023 | forbes.com

Best Multivitamins For Kids In 2023, According To Experts

October 19, 2022 | globenewswire.com

Nuwellis Announces Appointment of Chief Financial Officer - GlobeNewswire

October 18, 2022 | streetinsider.com

Form 424B4 Nuwellis, Inc. - StreetInsider.com

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

October 17, 2022 | uk.investing.com

Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday By Benzinga - Investing.com UK

October 14, 2022 | uk.investing.com

Why Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday's Mid-Day Session By Benzinga - Investing.com UK

October 14, 2022 | benzinga.com

Why Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday’s Mid-Day Session - Agri - Benzinga

October 14, 2022 | uk.investing.com

Why IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket By Benzinga - Investing.com UK

October 14, 2022 | globenewswire.com

Nuwellis Announces Pricing of $9.6 Million Upsized Underwritten Public Offering - GlobeNewswire

October 6, 2022 | marketscreener.com

NUWELLIS, INC. : Results of Operations and Financial Condition (form 8-K) - Marketscreener.com

October 6, 2022 | marketscreener.com

Nuwellis : Results of Operations and Financial Condition - Form 8-K - Marketscreener.com

October 5, 2022 | marketscreener.com

NUWELLIS, INC. : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K) - Marketscreener.com

October 4, 2022 | msn.com

U.S. shares higher at close of trade; Dow Jones Industrial Average up 2.66% - msnNOW

October 4, 2022 | streetinsider.com

Nuwellis (NUWE) Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA - StreetInsider.com

October 3, 2022 | in.investing.com

U.S. shares higher at close of trade; Dow Jones Industrial Average up 2.66% - Investing.com India

October 3, 2022 | benzinga.com

Nuwellis shares are trading higher after the company announced results of the AVOID-HF clinical study ana - Benzinga

October 3, 2022 | finance.yahoo.com

Nuwellis Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA Meeting - Yahoo Finance

October 3, 2022 | globenewswire.com

Nuwellis Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA Meeting - GlobeNewswire

September 27, 2022 | benzinga.com

Nuwellis Announces Activation Of New Sites For Its Pivotal REVERSE-HF Trial - Nuwellis (NASDAQ:NUWE) - Benzinga

September 27, 2022 | finance.yahoo.com

Nuwellis Announces the Activation of New Sites for Its Pivotal REVERSE-HF Trial - Yahoo Finance

September 27, 2022 | globenewswire.com

Nuwellis Announces the Activation of New Sites for Its Pivotal REVERSE-HF Trial - GlobeNewswire

September 23, 2022 | marketscreener.com

NUWELLIS, INC. : Change in Directors or Principal Officers (form 8-K) - Marketscreener.com

See More Headlines

Receive CHFS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuwellis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/01/2021
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Electromedical Equipment
Sub-Industry: N/A
Current Symbol: NASDAQ:CHFS
Previous Symbol: NASDAQ:SSH
CUSIP: N/A
CIK: 1506492
Web: www.chf-solutions.com
Phone: (952) 345-4200
Fax: N/A
Employees: 66
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($279.28)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-18,110,000.00
Net Margins: -254.26%
Pretax Margin: N/A
Return on Equity: -173.61%
Return on Assets: -131.01%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.87
Quick Ratio: 5.97

Sales & Book Value

Annual Sales: $5.51 million
Price / Sales: 0.29
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $12.79 per share
Price / Book: 0.02

Miscellaneous

Outstanding Shares: 6,037,000
Free Float: N/A
Market Cap: $1.57 million
Optionable: Not Optionable
Beta: 1.55

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Nestor Jaramillo
President, Chief Executive Officer, CFO & Director
Vitaliy Epshteyn
Senior Vice President-Operations & Engineering
David Lerner
Chief Technology Officer
Thomas P. Lynch
Secretary, Chief Legal & Compliance Officer
Laurent Duhoux
Vice President-International Business Development

Key Competitors

View All Competitors

CHFS Stock Analysis - Frequently Asked Questions

How were Nuwellis' earnings last quarter?: Nuwellis, Inc. (NASDAQ:CHFS) issued its earnings results on Monday, March, 1st. The company reported ($1.57) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.91) by $0.34. The company had revenue of $2.04 million for the quarter. Nuwellis had a negative net margin of 254.26% and a negative trailing twelve-month return on equity of 173.61%.
When did Nuwellis' stock split?: Nuwellis shares reverse split before market open on Friday, October 13th 2017. The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 12th 2017. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.
What other stocks do shareholders of Nuwellis own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Nuwellis investors own include Biocept (BIOC), Immutep (IMMP), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Zosano Pharma (ZSAN), Avinger (AVGR), Co-Diagnostics (CODX), iBio (IBIO), Inovio Pharmaceuticals (INO) and Onconova Therapeutics (ONTX).

This page (NASDAQ:CHFS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Nuwellis (CHFS) Stock Price, News & Analysis

About Nuwellis Stock (NASDAQ:CHFS)

CHFS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

CHFS Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info